ACPAs play a pivotal role in the progression of RA [11, 12], indicating a poor prognosis [4], more severe disease course and radiological destruction compared with patients with RA who are ACPA negative (−) [13]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.